15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer

/in /by

PanCareLIFE was well represented at the 15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer this week in Atlanta, Georgia. The conference focused on the exchange of innovative ideas among international medical and pediatric oncologists (including fellows and residents), nurse practitioners, oncology nurses, and other associated allied health professionals. This year’s symposium presented the latest scientific and clinical advances regarding the science and ethics of genomic testing.

The following were presented by PanCareLIFE researchers:

  • THE PANCARELIFE* CONSORTIUM: HEARING LOSS, INFERTILITY AND QUALITY OF LIFE IN EUROPEAN CHILDHOOD CANCER SURVIVORS – Julianne Byrne, Helen Campbell, Claudia Kuehni, Riccardo Haupt, Tomas Kepak, Jarmila Kruseova, Claire Berger, Jeanette Falck Winther, Flora van Leeuwen, Sophie Fossa, Alison Leiper, Victoria Grandage, Herwig Lackner, Maryna Krawczuk-Rybak, Anna Panasiuk, Arndt Borkhardt, Marina Kunstreich, Holger Cario, Eline van Dulmen-den Broeder, Gabi Calaminus, Anja Borgmann-Staudt, Uta Dirksen, Stefanie Hecker-Nolting, Antoinette am Zehnhoff-Dinnesen, Joanna Stefanowicz, Marry van den Heuvel-Eibrink, Dalit Modan-Moses, Thorsten Langer, Gabriele Strauss, Leontien Kremer, Kylie O’Brien, Desiree Grabow, Peter Kaatsch
  • FERTILITY STUDIES IN PANCARELIFE: A PAN-EUROPEAN CONSORTIUM STUDYING LATE EFFECTS OF CHILDHOOD CANCER – Marloes van Dijk, Marleen van den Berg, Julianne Byrne, Leontien Kremer, Helen Campbell, Claudia Kuehni, Vera Morsellino, Tomas Kepak, Jarmila Kruseova, Claire Berger, Sophie Fossa, Alison Leiper, Victoria Grandage, Flora van Leeuwen, Gabi Calaminus, Anja Borgmann-Staudt, Uta Dirksen, Dalit Modan-Moses, Jeanette Falck Winther, Kylie O’Brien, Desiree Grabow, Peter Kaatsch, Marry van den Heuvel-Eibrink, Eline van Dulmen-den Broeder
  • GENETIC DETERMINANTS OF GONADAL IMPAIRMENT IN FEMALE CHILDHOOD CANCER SURVIVORS: A PANCARE LIFE STUDY – A.L.F. van der Kooi, M. van Dijk, L. Broer, M. van den Berg, R. Haupt, K. Kepakova, J. Kruseova, C. Berger, F. van Leeuwen, S. Fössa, U. Dirksen, J.S.E. Laven, L.C. Kremer, D. Modan,  E. Clemens, P. Kaatsch, J. Byrne,  A. de Vries, A.G. Uitterlinden, E van Dulmen-den Broeder, M.M. van den Heuvel-Eibrink on behalf of the PanCareLIFE consortium
  • GENETIC VARIATION OF CISPLATIN-INDUCED OTOTOXICITY DURING CHILHDOOD CANCER TREATMENT: A PANCARELIFE STUDY – E. Clemens, T. Langer, L. Broer, A.G. Uitterlinden, B. Carleton, A.C.H. de Vries, C. Kuehni, R. Haupt , T. Kepak, J. Kruseova, J.F. Winther, L.C. Kremer, A.L.F. van der Kooi, D. Grabow, H. Binder, A. am Zehnhoff-Dinnesen, J. Byrne, P. Kaatsch, M.M. van den Heuvel-Eibrink and O. Zolk on behalf of the PanCareLIFE consortium
  • DEVELOPMENT AND VALIDATION OF A RISK MODEL FOR PREDICTING PLATINUM OTOTOXICITY IN CHILDHOOD CANCER PATIENTS: A PANCARELIFE STUDY – T. Langer, A. am Zehnhoff-Dinnesen, E. Clemens, L. Broer, A.G. Uitterlinden, A.C.H. de Vries, C. Kuehni, R. Haupt, T. Kepak, J. Kruseova, J.F. Winther, L. Kenborg, L.C. Kremer, A.L.F. van der Kooi, S. Hecker-Nolting, D. Grabow, H. Binder, J. Byrne, P. Kaatsch, M.M. van den Heuvel-Eibrink, O. Zolk, T. Paul, on behalf of the PanCareLIFE consortium
  • RISK FACTORS FOR NEGATIVE PSYCHOLOGICAL OUTCOME IN SURVIVORS AFTER CANCER TREATMENT IN CHILDHOOD – Kruseova J., Keslova P., Reichlova V., Smelhaus V., Kabickova E., Luks A., Capek V., Starý J., and Calaminus G.